MARYELLEN TUSSEY: Open Payments
NPI 1063026110 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 27 payments from 8 companies in 2025. Trend: 2023 $373 · 2024 $445 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Indivior Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, MAVYRET, Auvelity, AIRSUPRA, REXULTI, BRIXADI.
Industry payments across KY — which companies pay providers there.
